Article
Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia
22 Jan 2019
Abstract excerpt
Phenylalanine hydroxylase (PAH) deficiency is responsible for most cases of phenylketonuria (PKU). Furthermore, numerous studies on BH4-sensitive PAH deficiency have been conducted. To date, BH4, a cofactor of PAH, has not been used to treat PKU in Russia.Genotype data of patients with PKU can be used to predict their sensitivity to BH4 therapy. A cohort of 2579 patients with PKU from Russia was analyzed for 25...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
